JP2017500009A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017500009A5 JP2017500009A5 JP2016527261A JP2016527261A JP2017500009A5 JP 2017500009 A5 JP2017500009 A5 JP 2017500009A5 JP 2016527261 A JP2016527261 A JP 2016527261A JP 2016527261 A JP2016527261 A JP 2016527261A JP 2017500009 A5 JP2017500009 A5 JP 2017500009A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- domain
- sequence
- kit
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009472 formulation Methods 0.000 claims 26
- 239000000203 mixture Substances 0.000 claims 26
- 210000004027 cell Anatomy 0.000 claims 23
- 108020001756 ligand binding domains Proteins 0.000 claims 17
- 239000012636 effector Substances 0.000 claims 15
- 230000003834 intracellular effect Effects 0.000 claims 15
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims 14
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 14
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims 14
- 125000006850 spacer group Chemical group 0.000 claims 14
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 12
- 230000011664 signaling Effects 0.000 claims 11
- 210000000130 stem cell Anatomy 0.000 claims 11
- 230000004068 intracellular signaling Effects 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 7
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 6
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims 5
- 210000004698 lymphocyte Anatomy 0.000 claims 5
- 102100027207 CD27 antigen Human genes 0.000 claims 4
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 4
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims 4
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims 4
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims 4
- 239000002771 cell marker Substances 0.000 claims 4
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 3
- 101150029707 ERBB2 gene Proteins 0.000 claims 3
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 3
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 3
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 3
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims 3
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims 3
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims 3
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims 3
- 102000003735 Mesothelin Human genes 0.000 claims 3
- 108090000015 Mesothelin Proteins 0.000 claims 3
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 3
- 102000040856 WT1 Human genes 0.000 claims 3
- 108700020467 WT1 Proteins 0.000 claims 3
- 101150084041 WT1 gene Proteins 0.000 claims 3
- 230000003394 haemopoietic effect Effects 0.000 claims 3
- 210000000987 immune system Anatomy 0.000 claims 3
- 210000003643 myeloid progenitor cell Anatomy 0.000 claims 3
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 101710145634 Antigen 1 Proteins 0.000 claims 2
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 claims 2
- 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 claims 2
- -1 CD3ζ Proteins 0.000 claims 2
- 101150013553 CD40 gene Proteins 0.000 claims 2
- 101001039256 Caenorhabditis elegans Low-density lipoprotein receptor-related protein Proteins 0.000 claims 2
- 101100364669 Caenorhabditis elegans lin-18 gene Proteins 0.000 claims 2
- 102100024965 Caspase recruitment domain-containing protein 11 Human genes 0.000 claims 2
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 2
- 101000694288 Homo sapiens 40S ribosomal protein SA Proteins 0.000 claims 2
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 claims 2
- 101000914491 Homo sapiens B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 claims 2
- 101100166600 Homo sapiens CD28 gene Proteins 0.000 claims 2
- 101100005713 Homo sapiens CD4 gene Proteins 0.000 claims 2
- 101000761179 Homo sapiens Caspase recruitment domain-containing protein 11 Proteins 0.000 claims 2
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 2
- 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 claims 2
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 2
- 101001030069 Homo sapiens Major vault protein Proteins 0.000 claims 2
- 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 claims 2
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims 2
- 101001043564 Homo sapiens Prolow-density lipoprotein receptor-related protein 1 Proteins 0.000 claims 2
- 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 claims 2
- 101000738769 Homo sapiens Receptor-type tyrosine-protein phosphatase alpha Proteins 0.000 claims 2
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims 2
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims 2
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims 2
- 101001103033 Homo sapiens Tyrosine-protein kinase transmembrane receptor ROR2 Proteins 0.000 claims 2
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims 2
- 102000017578 LAG3 Human genes 0.000 claims 2
- 101150028321 Lck gene Proteins 0.000 claims 2
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims 2
- 101100364671 Mus musculus Ryk gene Proteins 0.000 claims 2
- 101100268066 Mus musculus Zap70 gene Proteins 0.000 claims 2
- 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 claims 2
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims 2
- 108010029755 Notch1 Receptor Proteins 0.000 claims 2
- 108010071083 Patched-2 Receptor Proteins 0.000 claims 2
- 102000007497 Patched-2 Receptor Human genes 0.000 claims 2
- 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 claims 2
- 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 claims 2
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims 2
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims 2
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims 2
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 2
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims 2
- 102100039616 Tyrosine-protein kinase transmembrane receptor ROR2 Human genes 0.000 claims 2
- 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 claims 2
- 210000001185 bone marrow Anatomy 0.000 claims 2
- 230000000139 costimulatory effect Effects 0.000 claims 2
- 230000001086 cytosolic effect Effects 0.000 claims 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical group FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 230000000638 stimulation Effects 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 1
- 206010065553 Bone marrow failure Diseases 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 208000029462 Immunodeficiency disease Diseases 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010033661 Pancytopenia Diseases 0.000 claims 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 208000018805 childhood acute lymphoblastic leukemia Diseases 0.000 claims 1
- 201000011633 childhood acute lymphocytic leukemia Diseases 0.000 claims 1
- 230000007547 defect Effects 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 230000007813 immunodeficiency Effects 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 201000002364 leukopenia Diseases 0.000 claims 1
- 208000004235 neutropenia Diseases 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361898387P | 2013-10-31 | 2013-10-31 | |
| US61/898,387 | 2013-10-31 | ||
| PCT/US2014/063576 WO2015066551A2 (en) | 2013-10-31 | 2014-10-31 | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020062173A Division JP7046112B2 (ja) | 2013-10-31 | 2020-03-31 | 改変された造血幹／前駆細胞及び非エフェクターｔ細胞、そしてそれらの用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017500009A JP2017500009A (ja) | 2017-01-05 |
| JP2017500009A5 true JP2017500009A5 (enExample) | 2017-12-14 |
| JP6685900B2 JP6685900B2 (ja) | 2020-04-22 |
Family
ID=53005396
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016527261A Active JP6685900B2 (ja) | 2013-10-31 | 2014-10-31 | 改変された造血幹／前駆細胞及び非エフェクターｔ細胞、そしてそれらの用途 |
| JP2020062173A Active JP7046112B2 (ja) | 2013-10-31 | 2020-03-31 | 改変された造血幹／前駆細胞及び非エフェクターｔ細胞、そしてそれらの用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020062173A Active JP7046112B2 (ja) | 2013-10-31 | 2020-03-31 | 改変された造血幹／前駆細胞及び非エフェクターｔ細胞、そしてそれらの用途 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20160250258A1 (enExample) |
| EP (2) | EP3063175A4 (enExample) |
| JP (2) | JP6685900B2 (enExample) |
| KR (1) | KR20160079854A (enExample) |
| CN (1) | CN105873952A (enExample) |
| AU (2) | AU2014342020C1 (enExample) |
| BR (1) | BR112016009898A2 (enExample) |
| CA (1) | CA2929087A1 (enExample) |
| IL (2) | IL245360B (enExample) |
| MX (1) | MX389160B (enExample) |
| NZ (2) | NZ719840A (enExample) |
| RU (1) | RU2733652C2 (enExample) |
| SG (2) | SG11201603228TA (enExample) |
| WO (1) | WO2015066551A2 (enExample) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2949648T3 (es) | 2012-12-20 | 2023-10-02 | Purdue Research Foundation | Células T que expresan un receptor antigénico quimérico como terapia contra el cáncer |
| US9511092B2 (en) | 2013-01-28 | 2016-12-06 | St. Jude Children's Research Hospital, Inc. | Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease |
| HRP20201906T1 (hr) | 2013-12-20 | 2021-04-02 | Fred Hutchinson Cancer Research Center | Označene kimerne efektorske molekule i njihovi receptori |
| JP6788573B6 (ja) | 2014-04-10 | 2020-12-16 | シアトル チルドレンズ ホスピタル， ディービーエー シアトル チルドレンズ リサーチ インスティテュート | メトトレキサートによる選択と組み合わせたＳｌｅｅｐｉｎｇ Ｂｅａｕｔｙトランスポゾンによる遺伝子改変Ｔ細胞の製造 |
| CN106459924A (zh) * | 2014-04-23 | 2017-02-22 | 得克萨斯州大学系统董事会 | 用于疗法中的嵌合抗原受体(car)及其制备方法 |
| KR20210014210A (ko) | 2014-05-15 | 2021-02-08 | 내셔널 유니버시티 오브 싱가포르 | 변형된 천연 살해 세포 및 그의 용도 |
| TWI805109B (zh) | 2014-08-28 | 2023-06-11 | 美商奇諾治療有限公司 | 對cd19具專一性之抗體及嵌合抗原受體 |
| CN107109438B (zh) | 2014-11-05 | 2021-09-03 | 朱诺治疗学股份有限公司 | 用于转导及细胞处理的方法 |
| AR103442A1 (es) | 2015-01-16 | 2017-05-10 | Juno Therapeutics Inc | Anticuerpos y receptores de antígenos quiméricos específicos de ror1 |
| US20170151281A1 (en) | 2015-02-19 | 2017-06-01 | Batu Biologics, Inc. | Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer |
| AU2016222887B2 (en) | 2015-02-24 | 2022-07-14 | The Regents Of The University Of California | Binding-triggered transcriptional switches and methods of use thereof |
| EP3288570A4 (en) | 2015-04-29 | 2018-11-21 | Fred Hutchinson Cancer Research Center | Modified stem cells and uses thereof |
| US20180355318A1 (en) * | 2015-04-29 | 2018-12-13 | Fred Hutchinson Cancer Research Center | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof |
| WO2016196388A1 (en) * | 2015-05-29 | 2016-12-08 | Juno Therapeutics, Inc. | Composition and methods for regulating inhibitory interactions in genetically engineered cells |
| US11173179B2 (en) | 2015-06-25 | 2021-11-16 | Icell Gene Therapeutics Llc | Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof |
| CN107849112B (zh) | 2015-06-25 | 2022-04-01 | 美商生物细胞基因治疗有限公司 | 嵌合抗原受体(car)、组合物及其使用方法 |
| GB201513540D0 (en) | 2015-07-31 | 2015-09-16 | King S College London | Therapeutic agents |
| CA2994829A1 (en) | 2015-08-07 | 2017-02-16 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Bispecific car t-cells for solid tumor targeting |
| AU2016336515B2 (en) * | 2015-10-06 | 2023-08-24 | City Of Hope | Chimeric antigen receptors targeted to PSCA |
| CN114181960B (zh) * | 2015-10-09 | 2024-08-23 | 美天施生物科技有限公司 | 嵌合抗原受体和使用方法 |
| JP6976960B2 (ja) * | 2015-11-27 | 2021-12-08 | カーサリクス プロプライエタリー リミテッド | 遺伝子改変された細胞およびその使用 |
| US20200297760A1 (en) * | 2015-12-03 | 2020-09-24 | Juno Therapeutics, Inc. | Compositions and methods for reducing immune responses against chimeric antigen receptors |
| WO2017177149A2 (en) | 2016-04-08 | 2017-10-12 | Purdue Research Foundation | Methods and compositions for car t cell therapy |
| US10188749B2 (en) | 2016-04-14 | 2019-01-29 | Fred Hutchinson Cancer Research Center | Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers |
| US11400116B2 (en) | 2016-05-06 | 2022-08-02 | The Regents Of The University Of California | Systems and methods for targeting cancer cells |
| EP4353750A3 (en) * | 2016-06-24 | 2024-07-24 | iCell Gene Therapeutics LLC | Chimeric antigen receptors (cars), compositions and methods thereof |
| CN106222145A (zh) * | 2016-08-22 | 2016-12-14 | 侯昌禾 | 一种用于治疗肿瘤的基因重组造血干细胞及其制备方法 |
| JP7500195B2 (ja) | 2016-08-23 | 2024-06-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | タンパク質分解により切断可能なキメラポリペプチド及びそれらの使用方法 |
| MX2019003768A (es) | 2016-10-03 | 2019-06-24 | Juno Therapeutics Inc | Moleculas de enlace especificas de hpv. |
| EP3564356A4 (en) * | 2016-11-04 | 2020-05-06 | The University Of Tokyo | SOLUTION FOR CRYOPRESERVATION, CRYOGENIZATION PRODUCT, AND METHOD FOR CRYOPRESERVATION OF ANIMAL CELLS OR ANIMAL TISSUES |
| CN106755107B (zh) * | 2016-11-22 | 2019-10-01 | 上海健信生物医药科技有限公司 | 一种car新分子及其在肿瘤治疗中的应用 |
| US11286306B2 (en) | 2016-12-09 | 2022-03-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | TLR9-binding chimeric antigen receptors |
| CN106755397A (zh) * | 2016-12-20 | 2017-05-31 | 江苏省肿瘤医院 | 基因多态性位点的用途和试剂盒 |
| WO2018118494A2 (en) * | 2016-12-22 | 2018-06-28 | Xiaotong Song | Use of car-modified human natural killer cells to treat cancer |
| CA3049244A1 (en) | 2017-01-05 | 2018-07-12 | Fred Hutchinson Cancer Research Center | Systems and methods to improve vaccine efficacy |
| ES3010559T3 (en) | 2017-02-28 | 2025-04-03 | Endocyte Inc | Compositions and methods for car t cell therapy |
| WO2018177971A1 (en) * | 2017-03-27 | 2018-10-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | New method to obtain lymphoid progenitors |
| IL269553B2 (en) | 2017-03-27 | 2025-10-01 | Nat Univ Singapore | Truncated NKG2D chimeric receptors and their uses in immunotherapy with natural killer cells |
| BR112019020001A2 (pt) | 2017-03-27 | 2020-04-28 | Nat Univ Singapore | linhagens celulares estimuladoras para expansão ex vivo e ativação de células exterminadoras naturais |
| US11149073B2 (en) | 2017-04-28 | 2021-10-19 | Julius-Maximilians-Universität Würzburg | ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains |
| JP2020524512A (ja) | 2017-06-21 | 2020-08-20 | アイセル・ジーン・セラピューティクス・エルエルシー | キメラ抗体受容体（ＣＡＲｓ）の組成物およびその使用方法 |
| CN107541499B (zh) * | 2017-07-27 | 2020-04-14 | 山东兴瑞生物科技有限公司 | 一种靶向免疫检测点tnfr2的cik的制备及其应用 |
| MX2020003536A (es) | 2017-10-03 | 2020-09-14 | Juno Therapeutics Inc | Moleculas de union especifica a virus de papiloma humano (hpv). |
| US10561686B2 (en) | 2018-01-12 | 2020-02-18 | Innovative Cellular Therapeutics CO., LTD. | Modified cell expansion and uses thereof |
| TW201940182A (zh) | 2018-01-22 | 2019-10-16 | 美商安德賽特公司 | Car t 細胞之使用方法 |
| PL3749334T3 (pl) | 2018-02-08 | 2025-04-07 | The Board Of Trustees Of The Leland Stanford Junior University | Allogeniczne przeszczepienie krwiotwórczych komórek macierzystych |
| JP7360174B2 (ja) | 2018-02-09 | 2023-10-12 | ナショナル ユニヴァーシティー オブ シンガポール | ナチュラルキラー細胞免疫療法における活性化キメラ受容体及びその使用 |
| JP7568224B2 (ja) | 2018-02-23 | 2024-10-16 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための配列決定法 |
| JP7334985B2 (ja) | 2018-04-02 | 2023-08-29 | ナショナル ユニヴァーシティー オブ シンガポール | 免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和 |
| RU2020135968A (ru) | 2018-04-05 | 2022-05-06 | Джуно Терапьютикс, Инк. | T-клеточные рецепторы и модифицированные клетки, экспрессирующие |
| US10869888B2 (en) | 2018-04-17 | 2020-12-22 | Innovative Cellular Therapeutics CO., LTD. | Modified cell expansion and uses thereof |
| WO2019229109A1 (en) * | 2018-05-30 | 2019-12-05 | Glycostem Therapeutics B.V. | Car nk cells |
| AU2019330347B2 (en) | 2018-08-29 | 2025-07-24 | National University Of Singapore | A method to specifically stimulate survival and expansion of genetically-modified immune cells |
| US12240915B2 (en) | 2018-08-30 | 2025-03-04 | Innovative Cellular Therapeutics Holdings, Ltd. | Chimeric antigen receptor cells for treating solid tumor |
| JP7627080B2 (ja) * | 2018-08-31 | 2025-02-05 | シアトル チルドレンズ ホスピタル ディー／ビー／エイ シアトル チルドレンズ リサーチ インスティテュート | Ｂ７ｈ３キメラ抗原受容体を含む方法および組成物 |
| EP3620510B1 (en) | 2018-09-06 | 2023-11-01 | Chr. Hansen HMO GmbH | Fermentative production of oligosaccharides by total fermentation utilizing a mixed feedstock |
| EP3876977A1 (en) | 2018-11-06 | 2021-09-15 | The Regents Of The University Of California | Chimeric antigen receptors for phagocytosis |
| US10918667B2 (en) | 2018-11-20 | 2021-02-16 | Innovative Cellular Therapeutics CO., LTD. | Modified cell expressing therapeutic agent and uses thereof |
| WO2020180882A1 (en) | 2019-03-05 | 2020-09-10 | Nkarta, Inc. | Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| JP7352307B2 (ja) * | 2019-03-15 | 2023-09-28 | 阿思科力（蘇州）生物科技有限公司 | 自殺遺伝子を持つｒｏｂｏ１ ｃａｒ－ｎｋ細胞、その製造方法及び使用 |
| US20220362304A1 (en) * | 2019-03-20 | 2022-11-17 | 2Seventy Bio, Inc. | Adoptive cell therapy |
| US11026973B2 (en) | 2019-04-30 | 2021-06-08 | Myeloid Therapeutics, Inc. | Engineered phagocytic receptor compositions and methods of use thereof |
| WO2020227446A1 (en) * | 2019-05-07 | 2020-11-12 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of polypeptides and chimeric antigen receptors via hinge domains |
| WO2020236612A1 (en) * | 2019-05-17 | 2020-11-26 | Deverra Therapeutics Inc. | Compositions and methods for improving treatment outcomes for patients having hematological malignancies using an expanded stem cell product |
| JP2022538397A (ja) * | 2019-06-19 | 2022-09-02 | ユリウス－マクシミリアン－ウニヴェルシテート・ヴュルツブルク | キメラ抗原受容体設計で実施するためのウルトラモジュラー（ｕｌｔｒａｍｏｄｕｌａｒ） ＩｇＧ３ベーススペーサードメイン及び多機能部位 |
| MX2022002613A (es) | 2019-09-03 | 2022-06-02 | Myeloid Therapeutics Inc | Metodos y composiciones para la integracion del genoma. |
| US10980836B1 (en) | 2019-12-11 | 2021-04-20 | Myeloid Therapeutics, Inc. | Therapeutic cell compositions and methods of manufacturing and use thereof |
| US12076343B2 (en) | 2020-02-19 | 2024-09-03 | Innovative Cellular Therapeutics Holdings, Ltd. | Engineered safety in cell therapy |
| US12043654B2 (en) | 2020-06-02 | 2024-07-23 | Innovative Cellular Therapeutics Holdings, Ltd. | Anti-GCC antibody and CAR thereof for treating digestive system cancer |
| CN112094817B (zh) * | 2020-09-23 | 2021-06-04 | 绿城农科检测技术有限公司 | 分泌丙硫氧嘧啶单克隆抗体的杂交瘤细胞株、单克隆抗体及应用 |
| JP2023549140A (ja) | 2020-11-04 | 2023-11-22 | マイエロイド・セラピューティクス，インコーポレーテッド | 操作されたキメラ融合タンパク質組成物およびその使用方法 |
| JP2024500847A (ja) | 2020-12-18 | 2024-01-10 | センチュリー セラピューティクス，インコーポレイテッド | 適合可能な受容体特異性を有するキメラ抗原受容体システム |
| AU2022237618A1 (en) | 2021-03-17 | 2023-10-12 | Create Medicines, Inc. | Engineered chimeric fusion protein compositions and methods of use thereof |
| WO2022241029A1 (en) | 2021-05-11 | 2022-11-17 | Myeloid Therapeutics, Inc. | Methods and compositions for genomic integration |
| EP4423145A1 (en) * | 2021-10-28 | 2024-09-04 | Lyell Immunopharma, Inc. | Methods for culturing cells expressing ror1-binding protein |
| JP2025508371A (ja) * | 2022-02-11 | 2025-03-26 | フレッド ハッチンソン キャンサー センター | Ｓｔｅａｐ１に結合するキメラ抗原受容体 |
| CN115433774A (zh) * | 2022-08-18 | 2022-12-06 | 浙江丰能医药科技有限公司 | 一种用于原发免疫性血小板减少症检测的生物标志物及其试剂盒 |
| WO2025059062A1 (en) * | 2023-09-11 | 2025-03-20 | The Trustees Of The University Of Pennsylvania | Genetic engineering of human hematopoietic stem/progenitor cells (hspcs) for locus-specific expression of therapeutic proteins |
| WO2025064828A1 (en) * | 2023-09-20 | 2025-03-27 | Kure.Ai, Inc. | Methods and reagents to improve cell therapy with the creation of novel car-targeting mr1 protein |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3753357A (en) | 1970-12-14 | 1973-08-21 | Ovitron Res Corp | Method and apparatus for the preservation of cells and tissues |
| US4199022A (en) | 1978-12-08 | 1980-04-22 | The United States Of America As Represented By The Department Of Energy | Method of freezing living cells and tissues with improved subsequent survival |
| US4559298A (en) | 1982-11-23 | 1985-12-17 | American National Red Cross | Cryopreservation of biological materials in a non-frozen or vitreous state |
| US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| US6291161B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
| ATE159548T1 (de) | 1990-11-13 | 1997-11-15 | Immunex Corp | Bifunktionelle wählbare fusionsgene |
| IE20030749A1 (en) | 1991-05-03 | 2003-11-12 | Indiana University Foundation | Human notch and delta binding domains in torporythmic proteins, and methods based thereon |
| US5856441A (en) | 1991-05-03 | 1999-01-05 | Yale University | Serrate fragments and derivatives |
| IL101728A (en) | 1991-05-03 | 2007-08-19 | Univ Yale | Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them |
| US5869282A (en) | 1991-12-11 | 1999-02-09 | Imperial Cancer Research Technology, Ltd. | Nucleotide and protein sequences of the serrate gene and methods based thereon |
| WO1993012141A1 (en) | 1991-12-11 | 1993-06-24 | Yale University | Nucleotide and protein sequences of the serrate gene and methods based thereon |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| EP1489097B1 (en) | 1994-01-11 | 2011-10-19 | Dyax Corporation | Inhibitors of human plasmin derived from kunitz domains and nucleic acids encoding the same |
| US5827642A (en) | 1994-08-31 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Rapid expansion method ("REM") for in vitro propagation of T lymphocytes |
| US5877299A (en) | 1995-06-16 | 1999-03-02 | Stemcell Technologies Inc. | Methods for preparing enriched human hematopoietic cell preparations |
| WO1997001571A1 (en) | 1995-06-28 | 1997-01-16 | Imperial Cancer Research Technology, Ltd. | Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| US5780300A (en) | 1995-09-29 | 1998-07-14 | Yale University | Manipulation of non-terminally differentiated cells using the notch pathway |
| AUPP221098A0 (en) | 1998-03-06 | 1998-04-02 | Diatech Pty Ltd | V-like domain binding molecules |
| AU770555B2 (en) * | 1998-08-17 | 2004-02-26 | Abgenix, Inc. | Generation of modified molecules with increased serum half-lives |
| WO2002059285A1 (en) | 2000-10-27 | 2002-08-01 | Fred Hutchinson Cancer Research Center | Methods for immortalizing cells |
| US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
| DK1791865T3 (da) | 2004-06-29 | 2010-11-01 | Immunocore Ltd | Celler der udtrykker en modificeret T-cellerecptor |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| CN105168250B (zh) | 2004-10-25 | 2019-02-05 | 塞勒兰特治疗公司 | 增殖骨髓细胞群体的方法及其应用 |
| EP1752471B9 (en) | 2005-01-05 | 2009-04-15 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| GB0504767D0 (en) | 2005-03-08 | 2005-04-13 | Ares Trading Sa | Lipocalin protein |
| CA2642020C (en) | 2006-02-14 | 2014-10-07 | Cellerant Therapeutics, Inc. | Methods and compositions for enhancing engraftment of hematopoietic stem cells |
| EP1829895A1 (en) | 2006-03-03 | 2007-09-05 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| EP2044956A4 (en) | 2006-06-14 | 2010-08-11 | Chugai Pharmaceutical Co Ltd | MEANS FOR PROMOTING THE PROLIFERATION OF HEMATOPOETIC STEM CELLS |
| US8003761B2 (en) * | 2007-01-23 | 2011-08-23 | Hoffmann-La Roche Inc. | Cancerous disease modifying antibodies |
| CA2700391A1 (en) | 2007-09-24 | 2009-04-02 | University Of Zuerich | Designed armadillo repeat proteins |
| WO2009091826A2 (en) * | 2008-01-14 | 2009-07-23 | The Board Of Regents Of The University Of Texas System | Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car) |
| WO2009097140A1 (en) * | 2008-01-30 | 2009-08-06 | Memorial Sloan-Kettering Cancer Center | Methods for off -the -shelf tumor immunotherapy using allogeneic t-cell precursors |
| PE20100362A1 (es) | 2008-10-30 | 2010-05-27 | Irm Llc | Derivados de purina que expanden las celulas madre hematopoyeticas |
| EA201190132A1 (ru) * | 2009-02-23 | 2013-01-30 | Гленмарк Фармасьютикалс С.А. | Гуманизированные антитела, связывающиеся с cd19, и их применение |
| ES2635316T3 (es) * | 2009-12-18 | 2017-10-03 | Kancera Ab | Anticuerpos contra ROR1 que pueden inducir muerte celular de LLC |
| EP3590520B1 (en) * | 2010-04-09 | 2021-12-29 | Fred Hutchinson Cancer Research Center | Compositions for providing hematopoietic function without hla matching |
| US20130095080A1 (en) | 2010-04-09 | 2013-04-18 | Fred Hutchinson Cancer Reserach Center | Compositions and methods for providing hematopoietic function |
| WO2012075158A1 (en) * | 2010-12-01 | 2012-06-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric rabbit/human ror1 antibodies |
| CA2858069C (en) * | 2011-12-08 | 2020-02-11 | Fred Hutchinson Cancer Research Center | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
| AU2013221672B2 (en) * | 2012-02-13 | 2017-11-09 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
-
2014
- 2014-10-31 CA CA2929087A patent/CA2929087A1/en active Pending
- 2014-10-31 BR BR112016009898A patent/BR112016009898A2/pt not_active Application Discontinuation
- 2014-10-31 NZ NZ719840A patent/NZ719840A/en not_active IP Right Cessation
- 2014-10-31 CN CN201480071639.7A patent/CN105873952A/zh active Pending
- 2014-10-31 SG SG11201603228TA patent/SG11201603228TA/en unknown
- 2014-10-31 NZ NZ758715A patent/NZ758715A/en not_active IP Right Cessation
- 2014-10-31 KR KR1020167014445A patent/KR20160079854A/ko not_active Ceased
- 2014-10-31 JP JP2016527261A patent/JP6685900B2/ja active Active
- 2014-10-31 RU RU2016121174A patent/RU2733652C2/ru active
- 2014-10-31 EP EP14859129.0A patent/EP3063175A4/en not_active Withdrawn
- 2014-10-31 SG SG10201803533YA patent/SG10201803533YA/en unknown
- 2014-10-31 AU AU2014342020A patent/AU2014342020C1/en active Active
- 2014-10-31 WO PCT/US2014/063576 patent/WO2015066551A2/en not_active Ceased
- 2014-10-31 US US15/033,518 patent/US20160250258A1/en not_active Abandoned
- 2014-10-31 MX MX2016005689A patent/MX389160B/es unknown
- 2014-10-31 EP EP22166188.7A patent/EP4083062A1/en not_active Withdrawn
-
2016
- 2016-05-01 IL IL245360A patent/IL245360B/en active IP Right Grant
-
2019
- 2019-06-18 US US16/445,053 patent/US20190381104A1/en not_active Abandoned
- 2019-06-24 AU AU2019204429A patent/AU2019204429B2/en active Active
-
2020
- 2020-01-28 IL IL272325A patent/IL272325B/en unknown
- 2020-03-31 JP JP2020062173A patent/JP7046112B2/ja active Active
-
2022
- 2022-11-28 US US18/059,369 patent/US20240041933A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017500009A5 (enExample) | ||
| RU2016121174A (ru) | МОДИФИЦИРОВАННЫЕ ГЕМОПОЭТИЧЕСКИЕ СТВОЛОВЫЕ КЛЕТКИ/КЛЕТКИ-ПРЕДШЕСТВЕННИКИ И Не-Т ЭФФЕКТОРНЫЕ КЛЕТКИ, И ИХ ПРИМЕНЕНИЕ | |
| JP2018521628A5 (enExample) | ||
| JP2015527070A5 (enExample) | ||
| US12161668B2 (en) | T cells expressing a chimeric antigen receptor | |
| IL284744B1 (en) | Chimeric antigen receptors gprc5d and cells expressing them | |
| JP2016520074A5 (enExample) | ||
| RU2019126655A (ru) | Нуклеиновые кислоты, кодирующие химерные рецепторы, полипептидные химерные рецепторы, кодируемые ими, векторы экспрессии, содержащие их, выделенные клетки-хозяева, содержащие их, композиции, содержащие выделенные клетки-хозяева, а также способы получения выделенных клеток-хозяев in vitro, способы выбора нуклеиновых кислот, кодирующих химерные рецепторы, in vitro и способы проведения клеточной иммунотерапии у субъекта, имеющего опухоль | |
| TW202039563A (zh) | 嵌合抗原及t細胞受體以及使用方法 | |
| RU2016129045A (ru) | Меченые химерные эффекторные молекулы и их рецепторы | |
| JP2018518939A5 (enExample) | ||
| KR20210089179A (ko) | Cll1을 표적으로 하는 항체 및 이의 응용 | |
| WO2018191748A1 (en) | Chimeric antigen receptor t cells targeting the tumor microenvironment | |
| JP2019503200A (ja) | 癌の治療のための組成物及び方法 | |
| JP2019513009A (ja) | 免疫療法用改変細胞 | |
| RU2018111462A (ru) | Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток | |
| HRP20211978T1 (hr) | Kimerični antigenski receptori koji ciljaju receptor spojen na g-protein i njihove uporabe | |
| TW201023863A (en) | Antitumor combinations containing antibodies recognizing specifically CD38 and cytarabine | |
| JP2021503006A5 (enExample) | ||
| JP2018508219A5 (enExample) | ||
| JP2017531687A5 (enExample) | ||
| JP2019532017A5 (enExample) | ||
| JP7319250B2 (ja) | Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用 | |
| US20230167190A1 (en) | Chimeric antigen receptors targeting cd37 | |
| JP2020535796A5 (enExample) |